CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
The study covered in this summary was published in researchsquare.com and has not yet been peer reviewed. This case–control study provided supportive evidence that previous proton pump inhibitor (PPI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results